|
PHACTR2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.66019999994871E-06 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.602000E-04 |
| Normal-vs-Stage2 |
1.137890E-02 |
| Normal-vs-Stage3 |
2.97259999948452E-08 |
| Normal-vs-Stage4 |
8.56099999779758E-08 |
| Stage1-vs-Stage2 |
9.588600E-01 |
| Stage1-vs-Stage3 |
2.557100E-03 |
| Stage1-vs-Stage4 |
6.192300E-04 |
| Stage2-vs-Stage3 |
7.266400E-02 |
| Stage2-vs-Stage4 |
1.929510E-02 |
| Stage3-vs-Stage4 |
3.393400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.03029999987525E-07 |
| Normal-vs-AfricanAmerican |
1.298590E-01 |
| Normal-vs-Asian |
3.039700E-03 |
| Caucasian-vs-AfricanAmerican |
1.242800E-01 |
| Caucasian-vs-Asian |
4.661200E-01 |
| AfricanAmerican-vs-Asian |
4.307600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.06389999999735E-05 |
| Normal-vs-Female |
4.52390000005298E-06 |
| Male-vs-Female |
6.449400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.335460E-03 |
| Normal-vs-Age(41-60Yrs) |
1.5002099999939E-05 |
| Normal-vs-Age(61-80Yrs) |
1.58049999998688E-06 |
| Normal-vs-Age(81-100Yrs) |
1.210190E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.668600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.097900E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.455200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.279400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.200200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.585000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.836200E-04 |
| Classical-VS-Follicular |
7.824400E-01 |
| Classical-VS-Other |
1.099410E-01 |
| Classical-VS-Normal |
1.211710E-04 |
| Tall-VS-Follicular |
5.401500E-03 |
| Tall-VS-Other |
7.430800E-01 |
| Tall-VS-Normal |
5.3574000014045E-08 |
| Follicular-VS-Other |
1.563190E-01 |
| Follicular-VS-Normal |
8.623400E-04 |
| Other-VS-Normal |
3.861300E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.77000000000094E-05 |
| Normal-vs-N1 |
1.50945999999319E-05 |
| N0-vs-N1 |
1.469620E-01 |
|
|
